Pharmidex is excited to support the 2025 Horizon Europe Marie Skłodowska-Curie Actions (MSCA) Staff Exchanges hybrid information session.
June 3, 2025
This initiative provides a fantastic opportunity to learn directly from key voices across the MSCA community, including insights from a project coordinator, beneficiary, and third-country partner, all sharing valuable lessons and best practices.
We are proud to announce that our Managing Director,
Professor
Mo Alavijeh (Pharmidex,
University of Hertfordshire), will participate in the Round Table Discussion on “MSCA Staff Exchanges: Challenges and Opportunities”, including an interactive Q&A session.
Mo will be attending in person at the
Universitat d'Alacant and is looking forward to engaging with attendees, building new connections, and exploring collaborative opportunities, particularly with those interested in working alongside a UK-based SME deeply committed to international research excellence.
Monika Holik,
Begoña Arano,
Sotirios Kiokias,
Rodrigo Gutierrez Dominguez,
Xavier Eekhout Chicharro,
Joaquin Silvestre,
Izaskun Lacunza,
Julio Marchamalo Amado,
Mónika Holik
Pharmidex is pleased to share that Ash Alavijeh , our Head of Operations, will be attending the Life Sciences Wallonia Business Forum this evening at the Residence of the Belgian Ambassador. Hosted by the Economic Counsellor of Belgium-Wallonia Investment & Trade, the event brings together leading organisations across the European life sciences sector to explore how Wallonia supports international growth both financially and strategically. We look forward to connecting with international partners and exploring opportunities for collaboration and innovation in the European life sciences ecosystem.
Pharmidex is proud to sponsor the SMR meeting Target Identification and Validation in Drug Discovery
We’re excited that Janette Dalay Robertson (Business Development Manager) and Ian Knowles (Head of Respiratory) will attend, eager to meet attendees, share ideas and explore new collaborations to advance drug discovery and development. At Pharmidex , we know robust target validation is key to successful therapeutics. Our expertise in biomarker analysis, histology, in vivo models, and autoimmune disease research supports innovation across translational medicine.
Pharmidex is delighted to announce our joint poster with VasoDynamics Ltd at Scotland’s Health Research and Innovation Conference on October 23rd in Edinburgh! We’re proud to be part of this inspiring event, organised by NHS Scotland and CSO Scotland , which brings together the brightest minds driving progress in health research, innovation, and life sciences. 📍 Visit our stand to learn more about our collaborative work. A printout of the poster will be available. Mo Alavijeh (FRSC, FRSM ) is looking forward to meeting attendees and discussing new opportunities for partnership and discovery. Together with VasoDynamics Ltd , we’re advancing science through collaboration and innovation. 🔗 Learn more about Pharmidex : www.pharmidex.com
